FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma. (Q46568257)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15980161 AND SRC:MED&resulttype=core&format=json

13 January 2020

title

FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15980161 AND SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

Fluorodeoxyglucose Positron Emission Tomography

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15980161 AND SRC:MED&resulttype=core&format=json

13 January 2020

author name string

N G Mikhaeel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15980161 AND SRC:MED&resulttype=core&format=json

13 January 2020

P A Fields

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15980161 AND SRC:MED&resulttype=core&format=json

13 January 2020

M J O'Doherty

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15980161 AND SRC:MED&resulttype=core&format=json

13 January 2020

A R Timothy

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15980161 AND SRC:MED&resulttype=core&format=json

13 January 2020

publication date

24 June 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15980161 AND SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15980161 AND SRC:MED&resulttype=core&format=json

13 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15980161 AND SRC:MED&resulttype=core&format=json

13 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15980161 AND SRC:MED&resulttype=core&format=json

13 January 2020

page(s)

1514-1523

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15980161 AND SRC:MED&resulttype=core&format=json

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

13 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDI272

Traditional treatment approaches in B-cell non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDI272

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDI272

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDI272

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDI272

Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDI272

Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDI272

Current treatment options in aggressive lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDI272

Early response to chemotherapy: a surrogate for final outcome of Hodgkin's disease patients that should influence initial treatment length and intensity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDI272

Hodgkin disease: prediction of outcome with 67Ga scintigraphy after one cycle of chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDI272

Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDI272

Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDI272

Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDI272

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDI272

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDI272

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15980161 AND SRC:MED&resulttype=core&format=json

release_dhnovoaghza2pif2hujupvwt3q

13 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dhnovoaghza2pif2hujupvwt3q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference